SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Orchestra BioMed Reports Third-Quarter 2026 Financial Results

NEW HOPE, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companie…

OBIO
SquawkNews Desk

NEW HOPE, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations with market-leading global medical device companie…

Related stories

Blackstone Infrastructure to Acquire Portland Natural Gas Transmission System M impact | EQUITY | Nov 10, 2026, 10:07 PM UTC Marsh & McLennan Agrees to Acquire Wilshire Marsh & McLennan agreed to acquire Wilshire from CC Capital and Motive Partners. M impact | EQUITY | Nov 10, 2026, 10:05 PM UTC Altius Reports Q3 Royalty Revenue of $33.3 Million Altius Minerals reported Q3 2026 attributable royalty revenue of $33.3 million and adjusted earnings of $10.6 million. The body also reports Q3 revenue of $19.6 million, versus $17 M impact | EQUITY | Nov 10, 2026, 10:05 PM UTC Altius reports Q3 royalty revenue of $33.3M and adjusted earnings of $10.6M M impact | EQUITY | Nov 10, 2026, 10:05 PM UTC Altius Reports Q3 2026 Royalty Revenue of $33.3M and Adjusted Earnings of $10.6M M impact | EQUITY | Nov 10, 2026, 10:05 PM UTC Andean Precious Metals Reports $197M Q3 Revenue, Cuts Golden Queen Output Guidance The company reported Q3 2026 net income of $32M and operating cash flow of $72M. Golden Queen production guidance fell to 37,000–40,000 oz from 43,000–50,000 oz, while cost guidanc M impact | EQUITY | Nov 10, 2026, 10:02 PM UTC